KSA Medical Cannabis Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

KSA medical cannabis market valued at $300M, driven by chronic illness demand and innovative delivery systems.

Region:Middle East

Author(s):Geetanshi

Product Code:KRAA0062

Pages:87

Published On:December 2025

About the Report

Base Year 2024

KSA Medical Cannabis Market Overview

  • The KSA Medical Cannabis Market is valued at USD 300 million, based on a five-year historical analysis. This growth is primarily driven by rising patient and physician awareness across the Middle East, where increasing prevalence of chronic illnesses and expanding research initiatives underpin demand for therapeutic alternatives. Innovations in delivery systems such as capsules, sprays, and transdermal patches are making cannabis-based treatments more accessible and user-friendly, further supporting market expansion.
  • Key players in this market include Aurora Cannabis Inc., Canopy Growth Corporation, Tilray Inc., GW Pharmaceuticals (Jazz Pharmaceuticals), and Organigram Holdings Inc. These companies play a significant role in driving growth and maintaining high standards in cannabis production and distribution, particularly in Saudi Arabia, which is a regional hub for medical cannabis due to its stringent medical regulations and controlled import policies.
  • Despite global trends, Saudi Arabia maintains a strict regulatory stance: cannabis and all derivatives remain fully illegal under the Law of Combating Narcotic Drugs and Psychotropic Substances, and no approvals for medical or industrial use have been granted, with the Saudi Food and Drug Authority having issued no licenses for cannabis products or trials.
KSA Medical Cannabis Market Size

KSA Medical Cannabis Market Segmentation

By Type:The market is segmented into various types of cannabis products, including flower, oils, edibles, capsules, topicals, and others. Among these, oils and capsules are gaining significant traction due to their ease of use and precise dosing, appealing to both patients and healthcare providers. The demand for flower products remains strong, particularly among traditional users, while edibles are emerging as a popular choice for those seeking alternative consumption methods. The diverse product offerings cater to a wide range of patient preferences and therapeutic needs.

KSA Medical Cannabis Market segmentation by Type.

By End-User:The end-user segmentation includes hospitals, clinics, home care, research institutions, and others. Hospitals and clinics are the primary consumers of medical cannabis products, driven by the increasing acceptance of cannabis as a legitimate treatment option for various medical conditions. Home care is also emerging as a significant segment, particularly for patients seeking alternative therapies in a comfortable setting. Research institutions are vital for advancing clinical studies and validating the efficacy of cannabis treatments.

KSA Medical Cannabis Market segmentation by End-User.

KSA Medical Cannabis Market Competitive Landscape

The KSA Medical Cannabis Market is characterized by a dynamic mix of regional and international players. Leading participants such as Bedrocan, Canopy Growth Corporation, Aurora Cannabis, Tilray, MedReleaf, Curaleaf, Trulieve, Aphria, Harvest Health & Recreation, Green Thumb Industries, Cresco Labs, Organigram, Hexo Corp, Cronos Group, Emblem Corp contribute to innovation, geographic expansion, and service delivery in this space.

Bedrocan

2008

Netherlands

Canopy Growth Corporation

2013

Canada

Aurora Cannabis

2006

Canada

Tilray

2013

Canada

MedReleaf

2013

Canada

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Diversification Index

KSA Medical Cannabis Market Industry Analysis

Growth Drivers

  • Non-Oil GDP Expansion:In future, Saudi Arabia's non-oil economic activities grew by 4.3 percent, reflecting a shift towards diversification from oil dependency. This growth enhances disposable incomes, leading to increased healthcare spending. As healthcare budgets expand, the acceptance and integration of alternative therapies, including medical cannabis, are likely to rise, fostering a more favorable environment for market development. Source: Reuters (General Authority for Statistics).
  • Pharmaceutical Market Scale:The pharmaceutical market in Saudi Arabia is projected to reach USD 6.93 billion in future, driven by local capacity and innovation. This growth supports the adoption of alternative therapies, including medical cannabis, as healthcare providers seek effective treatments for various conditions. The expanding pharmaceutical landscape indicates a readiness for integrating medical cannabis into therapeutic options, enhancing patient care. Source: Arab News Japan.
  • Drug Testing Market Revenue:In future, the drug-of-abuse testing services market generated USD 11.6 million, with cannabis being the largest segment. This high volume of testing indicates a robust infrastructure for cannabis-related clinical awareness. The existing testing framework can be adapted for medical cannabis, facilitating its acceptance and integration into healthcare practices, thereby driving market growth. Source: Grand View Research.

Market Challenges

  • Strict Legal Prohibition:Currently, there is no legal framework for medical cannabis in Saudi Arabia, with CBD also classified as illegal. This absolute prohibition severely restricts market development and limits research opportunities. The lack of a legal medical cannabis program creates significant barriers for potential investors and healthcare providers, stifling innovation and access to alternative therapies. Source: Cannabislaws.global.
  • High Drug-Related Enforcement:In future, over 4,500 drug-related arrests were reported, with significant quantities of CBD products seized. This aggressive enforcement strategy suppresses informal demand and deters research initiatives. The stringent legal environment creates a climate of fear, hindering the exploration of medical cannabis benefits and discouraging potential stakeholders from entering the market. Source: Eleventhc blog data.

KSA Medical Cannabis Market Future Outlook

The future of the KSA medical cannabis market appears promising, despite current legal restrictions. With a projected market size of USD 368.1 million in future, there is significant potential for growth if regulations evolve. The increasing interest in therapeutic benefits and the expansion of testing infrastructure indicate a readiness for market entry. As public awareness grows and legal frameworks adapt, the medical cannabis sector could see substantial development, aligning with global trends in alternative therapies.

Market Opportunities

  • CBD Market Expansion:The CBD products market was valued at USD 100 million in future. If regulations shift, this existing consumer base could transition into medical cannabis acceptance, creating new sales channels and enhancing market viability. The potential for growth in this segment is significant, given the rising interest in alternative therapies. Source: IMARC Group.
  • Medical Segment in Legalized Market:In a potential legalized cannabis market projected at USD 538.31 million in future, the medical segment is expected to dominate. This indicates a clear demand opportunity for medical cannabis if regulatory changes occur, allowing for the development of therapeutic products tailored to patient needs. Source: Reed Intelligence.

Scope of the Report

SegmentSub-Segments
By Type

Flower

Oils

Edibles

Capsules

Topicals

Others

By End-User

Hospitals

Clinics

Home Care

Research Institutions

Others

By Patient Demographics

Age Group (Pediatric, Adult, Geriatric)

Gender

Medical Conditions (Chronic Pain, Anxiety, etc.)

Others

By Distribution Channel

Pharmacies

Online Retail

Direct Sales

Others

By Formulation

Sativa

Indica

Hybrid

Others

By Geographic Distribution

Urban Areas

Rural Areas

Others

By Policy Support

Subsidies

Tax Exemptions

Research Grants

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Saudi Food and Drug Authority, Ministry of Health)

Manufacturers and Producers

Distributors and Retailers

Pharmaceutical Companies

Healthcare Providers and Practitioners

Industry Associations

Financial Institutions

Players Mentioned in the Report:

Bedrocan

Canopy Growth Corporation

Aurora Cannabis

Tilray

MedReleaf

Curaleaf

Trulieve

Aphria

Harvest Health & Recreation

Green Thumb Industries

Cresco Labs

Organigram

Hexo Corp

Cronos Group

Emblem Corp

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. KSA Medical Cannabis Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 KSA Medical Cannabis Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. KSA Medical Cannabis Market Analysis

3.1 Growth Drivers

3.1.1 Increasing Acceptance of Medical Cannabis
3.1.2 Rising Demand for Alternative Therapies
3.1.3 Government Support and Regulation
3.1.4 Expansion of Research and Development

3.2 Market Challenges

3.2.1 Regulatory Uncertainty
3.2.2 Stigma and Public Perception
3.2.3 Limited Access to Quality Products
3.2.4 High Initial Investment Costs

3.3 Market Opportunities

3.3.1 Development of New Product Lines
3.3.2 Export Potential to Neighboring Markets
3.3.3 Collaborations with Healthcare Providers
3.3.4 Technological Advancements in Cultivation

3.4 Market Trends

3.4.1 Increasing Research on Cannabinoids
3.4.2 Growth of E-commerce Platforms
3.4.3 Focus on Sustainable Cultivation Practices
3.4.4 Rise of Personalized Medicine

3.5 Government Regulation

3.5.1 Licensing Requirements for Producers
3.5.2 Quality Control Standards
3.5.3 Restrictions on Marketing and Advertising
3.5.4 Taxation Policies on Medical Cannabis Products

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. KSA Medical Cannabis Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. KSA Medical Cannabis Market Segmentation

8.1 By Type

8.1.1 Flower
8.1.2 Oils
8.1.3 Edibles
8.1.4 Capsules
8.1.5 Topicals
8.1.6 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Home Care
8.2.4 Research Institutions
8.2.5 Others

8.3 By Patient Demographics

8.3.1 Age Group (Pediatric, Adult, Geriatric)
8.3.2 Gender
8.3.3 Medical Conditions (Chronic Pain, Anxiety, etc.)
8.3.4 Others

8.4 By Distribution Channel

8.4.1 Pharmacies
8.4.2 Online Retail
8.4.3 Direct Sales
8.4.4 Others

8.5 By Formulation

8.5.1 Sativa
8.5.2 Indica
8.5.3 Hybrid
8.5.4 Others

8.6 By Geographic Distribution

8.6.1 Urban Areas
8.6.2 Rural Areas
8.6.3 Others

8.7 By Policy Support

8.7.1 Subsidies
8.7.2 Tax Exemptions
8.7.3 Research Grants
8.7.4 Others

9. KSA Medical Cannabis Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Diversification Index
9.2.8 Distribution Efficiency
9.2.9 Brand Recognition Score
9.2.10 Regulatory Compliance Rate

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Bedrocan
9.5.2 Canopy Growth Corporation
9.5.3 Aurora Cannabis
9.5.4 Tilray
9.5.5 MedReleaf
9.5.6 Curaleaf
9.5.7 Trulieve
9.5.8 Aphria
9.5.9 Harvest Health & Recreation
9.5.10 Green Thumb Industries
9.5.11 Cresco Labs
9.5.12 Organigram
9.5.13 Hexo Corp
9.5.14 Cronos Group
9.5.15 Emblem Corp

10. KSA Medical Cannabis Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Agriculture
10.1.3 Ministry of Commerce
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Research Facilities
10.2.2 Funding for Clinical Trials
10.2.3 Infrastructure Development
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Access to Quality Products
10.3.2 Cost of Treatment
10.3.3 Regulatory Hurdles
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training Needs
10.4.3 Acceptance of Medical Cannabis
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Treatment Efficacy
10.5.2 Expansion into New Therapeutic Areas
10.5.3 Long-term Patient Outcomes
10.5.4 Others

11. KSA Medical Cannabis Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of existing market reports and white papers on medical cannabis in KSA
  • Review of government publications and regulatory frameworks regarding cannabis use
  • Examination of demographic and health statistics from the Saudi Ministry of Health

Primary Research

  • Interviews with healthcare professionals specializing in pain management and oncology
  • Surveys with pharmacists and dispensary operators regarding product availability and consumer preferences
  • Focus groups with patients and caregivers to understand perceptions and experiences with medical cannabis

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and stakeholder feedback
  • Triangulation of data from healthcare providers, regulatory bodies, and market analysts
  • Sanity checks through comparison with international medical cannabis market trends

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total addressable market based on national healthcare expenditure and cannabis-related spending
  • Segmentation of market size by therapeutic areas such as chronic pain, epilepsy, and cancer treatment
  • Incorporation of projected patient population growth and changing healthcare policies

Bottom-up Modeling

  • Collection of sales data from licensed medical cannabis producers and distributors
  • Estimation of average price points for various cannabis products in the KSA market
  • Volume estimates based on patient prescriptions and consumption patterns

Forecasting & Scenario Analysis

  • Multi-variable forecasting using factors such as regulatory changes, public acceptance, and healthcare trends
  • Scenario analysis based on potential shifts in legislation and market entry of new products
  • Development of baseline, optimistic, and pessimistic market growth projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Healthcare Professionals150Doctors, Nurses, Pain Management Specialists
Pharmacy Sector100Pharmacists, Pharmacy Managers
Patient Insights80Patients with chronic conditions, Caregivers
Regulatory Bodies50Government Officials, Policy Makers
Industry Experts70Market Analysts, Cannabis Industry Consultants

Frequently Asked Questions

What is the current value of the KSA Medical Cannabis Market?

The KSA Medical Cannabis Market is currently valued at approximately USD 300 million, driven by increasing patient and physician awareness, the prevalence of chronic illnesses, and innovations in cannabis delivery systems such as capsules and sprays.

Who are the key players in the KSA Medical Cannabis Market?

What are the main types of cannabis products available in the KSA market?

What challenges does the KSA Medical Cannabis Market face?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022